Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Raül Rigo-Bonnin"'
Autor:
Cristina El Haj, Eugènia Agustí, Eva Benavent, Laura Soldevila-Boixader, Raül Rigo-Bonnin, Fe Tubau, Benjamín Torrejón, Jaime Esteban, Oscar Murillo
Publikováno v:
Antibiotics, Vol 13, Iss 4, p 344 (2024)
Background: As the anti-biofilm pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics are not well-defined, we have evaluated the PK/PD indices for different regimens of ceftazidime (CAZ; with/without colistin) against Pseudomonas aerugin
Externí odkaz:
https://doaj.org/article/a5718c5305c743fd93ffad1b8f37c169
Autor:
Pere Fontova, Lisanne N. van Merendonk, Anna Vidal-Alabró, Raül Rigo-Bonnin, Gema Cerezo, Stefaan van Oevelen, Oriol Bestard, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Joan Torras, Josep M. Cruzado, Josep M. Grinyó, Helena Colom, Nuria Lloberas
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1481 (2023)
Despite intensive monitoring of whole blood tacrolimus concentrations, acute rejection after kidney transplantation occurs during tacrolimus therapy. Intracellular tacrolimus concentrations could better reflect exposure at the site of action and its
Externí odkaz:
https://doaj.org/article/17151f14f7b844a0abfe1718be0a1db2
Autor:
Javier Martínez-Casanova, Erika Esteve-Pitarch, Helena Colom-Codina, Víctor Daniel Gumucio-Sanguino, Sara Cobo-Sacristán, Evelyn Shaw, Kristel Maisterra-Santos, Joan Sabater-Riera, Xosé L. Pérez-Fernandez, Raül Rigo-Bonnin, Fe Tubau-Quintano, Jordi Carratalà, Ariadna Padullés-Zamora
Publikováno v:
Antibiotics, Vol 12, Iss 3, p 531 (2023)
Critically ill patients undergo significant pathophysiological changes that affect antibiotic pharmacokinetics. Piperacillin/tazobactam administered by continuous infusion (CI) improves pharmacokinetic/pharmacodynamic (PK/PD) target attainment. This
Externí odkaz:
https://doaj.org/article/7d332f6e743a44688ac604b8a5c70ea0
Autor:
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, Lisanne N. van Merendonk, Anna Vidal-Alabró, Nuria Montero, Edoardo Melilli, Maria Meneghini, Anna Manonelles, Josep M. Cruzado, Juan Torras, Josep Maria Grinyó, Oriol Bestard, Nuria Lloberas
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Tacrolimus is the backbone immunosuppressant after solid organ transplantation. Tacrolimus has a narrow therapeutic window with large intra- and inter-patient pharmacokinetic variability leading to frequent over- and under-immunosuppres
Externí odkaz:
https://doaj.org/article/919fc8842deb4744a8f2acf7f43d07ac
Autor:
Sara, Otero Torres, Roser, Juvany Roig, Mercè, Falip Centellas, Miriam, Casellas Gibert, Mónica, Estopiñá Antolí, Raül, Rigo Bonnin, Jacint Xavier, Sala-Padro, Ramón, Jódar Massanés
Publikováno v:
Clinical Neuropharmacology. 46:39-42
The reference range for lacosamide (LCM) has been updated from 1 to 10 mg/L to 10 to 20 mg/L. Historically, LCM range was defined from trough-level measurements, but the newer ranges were obtained from peak-level measurements. The purpose of the stud
Autor:
Eduard Fort Casamartina, Carme Muñoz Sanchez, Raül Rigo-Bonnin, Núria Gonzalo Diego, Sara Otero Torres, Carmen Bleda Perez, Judith Prats Jimenez, Sandra Fontanals Martínez
Everolimus is an inhibitor of mammalian target of rapamycin (mTOR) widely used as an immunosuppressant in transplant patients. In transplantation setting, several recommendations for therapeutic drug monitoring are available, due to potential drug-dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54953d7a4c519b52fd6aef6f292ba9cb
https://doi.org/10.22541/au.167985365.54839192/v1
https://doi.org/10.22541/au.167985365.54839192/v1
Autor:
Xavier Solanich, Xose-Luís Pérez-Fernández, Luisa Corral-Ansa, Salvador Ventura-Pedret, Merce Gasa, Víctor-Daniel Gumucio-Sanguino, Enric Boza-Hernandez, Enrique Hernández-Jiménez, Joan Sabater-Riera, Raül Rigo-Bonnin, Maria Pons-Serra, MariPaz Fuset-Cabanes
Publikováno v:
Clinical Biochemistry
Graphical abstract
Background Currently, good prognosis and management of critically ill patients with COVID-19 are crucial for developing disease management guidelines and providing a viable healthcare system. We aimed to propose individual out
Background Currently, good prognosis and management of critically ill patients with COVID-19 are crucial for developing disease management guidelines and providing a viable healthcare system. We aimed to propose individual out
Autor:
Fe Tubau-Quintano, Jordi Carratalà, Víctor Daniel Gumucio-Sanguino, Xose L. Perez-Fernandez, Erika Esteve-Pitarch, Kristel Maisterra-Santos, Sara Cobo-Sacristán, Evelyn Shaw, Helena Colom-Codina, Joan Sabater-Riera, Raül Rigo-Bonnin, Ariadna Padullés-Zamora
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics. 46:527-538
Morbidity and mortality from serious infections are common in intensive care units (ICUs). The appropriateness of the antibiotic treatment is essential to combat sepsis. We aimed to evaluate pharmacokinetic/pharmacodynamic target attainment of merope
Autor:
Beatriz Fernández-Alarcón, Oscar Nolberger, Anna Vidal-Alabró, Raul Rigo-Bonnin, Josep M. Grinyó, Edoardo Melilli, Nuria Montero, Anna Manonelles, Ana Coloma, Alex Favà, Sergi Codina, Josep M. Cruzado, Helena Colom, Nuria Lloberas
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
AimsThe once-daily extended-release tacrolimus formulation (ER-Tac) has demonstrated similar efficacy and safety to the twice-daily immediate-release formulation (IR-Tac), but few population-based pharmacokinetic models have been developed in de novo
Externí odkaz:
https://doaj.org/article/e1e7a764787d4907916c5088a819c282
Autor:
Raül Rigo-Bonnin, Francesca Canalias
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 59:e1-e7